Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

  • January 2014
  • -
  • Asia Market Information & Development Company
  • -
  • 2438 pages

China's demand for cancer treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.

This is a collection of 12 full market research reports:

821 Lung Cancer Treatment Drugs Markets in China
822 Breast Cancer Treatment Drugs Markets in China
823 Prostate Cancer Treatment Drugs Markets in China
824 Leukemia Treatment Drugs Markets in China
826 Ovarian Cancer Treatment Drugs Markets in China
827 Colon Cancer Treatment Drugs Markets in China
828 Cervical Cancer Treatment Drugs Markets in China
829 Brain Cancer Treatment Drugs Markets in China
830 Bladder Cancer Treatment Drugs Markets in China
843 Liver Cancer Treatment Drugs Markets in China
844 Kidney Cancer Treatment Drugs Markets in China
845 Skin Cancer Treatment Drugs Markets in China

These new studies examine China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

Table Of Contents

Cancer Treatment Drugs Markets in China (12 Full Research Reports Collection)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • January 2015
  • by Global Data

PharmaPoint: HER2-Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary Breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. ...

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018

  • $ 7 995
  • Industry report
  • January 2015
  • by Global Data

OpportunityAnalyzer: Cushing’s Syndrome - Opportunity Analysis and Forecasts to 2018 Summary GlobalData estimates that the 2013 sales for the Cushing’s syndrome (CS) therapeutic market was approximately ...

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • December 2014
  • by GBI Research

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation Summary Large and Diverse Pipeline The liver cancer pipeline contains 238 products in active development, approximately ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.